Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03379959

Ligand	Ligand name	Chain	PDB	Tanimoto
TES	TESTOSTERONE	A	1JTV	0.72
TES	TESTOSTERONE	A	2Q7L	0.72
TES	TESTOSTERONE	A	2Q7I	0.72
TES	TESTOSTERONE	A,B	1J96	0.72
TES	TESTOSTERONE	A	2Q7K	0.72
TES	TESTOSTERONE	A,B	1Q13	0.72
TES	TESTOSTERONE	H	1I9J	0.72
TES	TESTOSTERONE	A,B	1AFS	0.72
TES	TESTOSTERONE	H	1VPO	0.72
TES	TESTOSTERONE	A	2Q7J	0.72
TES	TESTOSTERONE	A,B	3BUR	0.72
TES	TESTOSTERONE	A	2AM9	0.72
PLO	(3BETA)-3-HYDROXYPREGN-5-EN-20-ONE	A	1Q20	0.71
ASD	4-ANDROSTENE-3-17-DIONE	A,B	3CAS	0.71
ASD	4-ANDROSTENE-3-17-DIONE	A	1QYX	0.71
ASD	4-ANDROSTENE-3-17-DIONE	A,B,C,D	2VCT	0.71
ASD	4-ANDROSTENE-3-17-DIONE	A	1EUP	0.71
ASD	4-ANDROSTENE-3-17-DIONE	A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P	2VCV	0.71
ASD	4-ANDROSTENE-3-17-DIONE	A	3EQM	0.71
ASD	4-ANDROSTENE-3-17-DIONE	A	1XF0	0.71
ANB	ANDROSTA-1,4-DIENE-3,17-DIONE	A	1H62	0.71
TH2	TESTOSTERONE HEMISUCCINATE	A,B	2CBT	0.7
TH2	TESTOSTERONE HEMISUCCINATE	A,B,C,D,E,F	2CBQ	0.7
TH2	TESTOSTERONE HEMISUCCINATE	A	2CBO	0.7
DL4	(14beta,17alpha,25R)-3-oxocholest-4-en-26-oic acid	A	3GYT	0.77
CLL	CHOLESTERYL LINOLEATE	A,B	1CLE	0.75
STR	PROGESTERONE	A	1H60	0.71
STR	PROGESTERONE	A,B,C	1YA3	0.71
STR	PROGESTERONE	A,B	2AA6	0.71
STR	PROGESTERONE	A	1MRQ	0.71
STR	PROGESTERONE	A,B	1A28	0.71
STR	PROGESTERONE	A,B	2AA5	0.71
STR	PROGESTERONE	A	2HZQ	0.71
STR	PROGESTERONE	A	1W0F	0.71
STR	PROGESTERONE	A	2ABA	0.71
STR	PROGESTERONE	A,B	3COT	0.71
STR	PROGESTERONE	H	1DBB	0.71
STR	PROGESTERONE	H,L	2O5Y	0.71
0MA	maslinic acid	A	2QN2	0.71
1CA	DESOXYCORTICOSTERONE	A,B	1Y9R	0.71
1CA	DESOXYCORTICOSTERONE	A,B,C	2ABI	0.71
1CA	DESOXYCORTICOSTERONE	A	2Q3Y	0.71
1CA	DESOXYCORTICOSTERONE	A	2AA7	0.71
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPG	0.72
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPJ	0.72
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPF	0.72
OPD	9R,13R-12-OXOPHYTODIENOIC ACID	A,B	1ICQ	0.72
0AS	asiatic acid	A	2QN1	0.71
1PL	(1S,3aS,5aR,8aS)-1,7,7-trimethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene-4-carboxylic acid	A	2RDS	0.73
1PL	(1S,3aS,5aR,8aS)-1,7,7-trimethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene-4-carboxylic acid	A	2RDN	0.73
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A,B	1E3R	0.72
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	3DHE	0.72
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1J99	0.72
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1COY	0.72
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1Q22	0.72
2OB	CHOLESTERYL OLEATE	A	2OBD	0.75
NDR	(14beta,17alpha)-17-ethynyl-17-hydroxyestr-4-en-3-one	A,B	1SQN	0.71
NDR	(14beta,17alpha)-17-ethynyl-17-hydroxyestr-4-en-3-one	A,B	2W8Y	0.71
NTH	SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER	A,B	1BUQ	0.71
CBW	(3BETA,5BETA,14BETA)-3-HYDROXY-11-OXOOLEAN-12-EN-29-OIC ACID	A	2W4Q	0.74
NOG	13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE	A	1LHV	0.71
NOG	13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE	A,B	3D90	0.71